Cerliponase alfa ▼ is not registered in all countries, and where it is registered the content of its indication along with other content may vary.
Please refer to your local prescribing information before prescribing cerliponase alfa.
▼ This medicinal product is subject to additional monitoring, special reporting is required in relation to adverse reactions. Email us at medinfo@bmrn.com for further details.
Welcome to the resources home page, you will find a collection of materials designed to support your clinical practice- navigate through the different sections to explore up-to-date publications, clinical tools, insights, and educational content developed for healthcare professionals. Stay informed on the latest advancements and catch up on demand content from recent events.
On Demand
During this webinar, first broadcast at the BioMarin sponsored CLN2 Masterclass 2021, Professor Stéphane Auvin from the Robert Debré University Hospital & Université de Paris, Paris, France, focusses on treatable infantile epilepsy (with a particular focus about myoclonic epilepsies), how to identify them and how to diagnose as early as possible.
Infographic
On Demand
On Demand
On Demand